Research and clinical interests of Andrew D. Barreto, M.D., include combination treatments for thrombolysis, ultrasound-enhanced and endovascular treatments for stroke and CT and MRI vascular neuroimaging. He was lead author of a study showing that a hands-free ultrasound device in combination with tissue plasminogen activator (tPA) was safe. The results were published in the October 2013 issue of Stroke, the journal of the American Heart Association.
Nicole R. Gonzales, M.D., researches neuroprotection in ischemic stroke, acute treatment of ischemic stroke and intracerebral hemorrhage, and stroke prevention and education. Her clinical interests include experimental treatments for intracerebral hemorrhage, neuroimaging and the natural history of intracerebral hemorrhage. She received the 2009 UTHealth Young Investigators Award for her work studying the medication pioglitazone for intracerebral hemorrhage.
Nneka Ifejika, M.D., M.P.H., specializes in neurorehabilitation, with an emphasis on stroke and multiple sclerosis. Her clinical interests include addressing health disparities and stroke outcomes with the long term goal of improving disability in high risk populations. Her research includes interventions and medications that affect post-acute stroke outcomes and long-term rehabilitation outcomes.
The clinical and research interests of Elizabeth Noser, M.D., include acute stroke care, rehabilitation and community outreach and education. She completed a combined vascular neurology and neurorecovery fellowship at the UTHealth Medical School and has served as medical director of neurorehabilitation at the Mischer Neuroscience Institute at Memorial Hermann-Texas Medical Center. Dr. Noser is a member of the UTHealth Stroke Team and co-principal investigator for the UTHealth Mobile Stroke Unit study.
Sean I. Savitz, M.D., specializes in the treatment and research of acute stroke. His research includes using autologous stem cells after acute stroke given intravenously and subacute stroke given by intra-carotid administration; using umbilical cord tissue-derived cells for acute ischemic stroke; and using tPA in patients who wake up with symptoms of stroke.
Previous Interview: http://bit.ly/n6DlV5